"ABO Incompatibility as a Prognostic Factor in Allogeneic Stem Cell Transplantation."

According to an abstract submitted by the authors to the 51st Annual Meeting of the American Association of Blood Banks, held October 31 - November 4, 1998, in Philadelphia, Pennsylvania, "Background: Allogeneic stem cell transplantation across ABO barriers may result in a variety of immune-mediated disorders, ranging from hemolysis to RBC aplasia. These complications may either be avoided or respond to supportive care and have not been associated with poor outcomes. We therefore adopted a policy in ABO incompatible transplantation that incorporated minimal manipulation of the recipient and the graft or of transfused blood components after transplantation. Methods: A...

Want to see the full article?

• Purchase this article for only $3.00